Human hand holding dog paw

LexaGene Finalizes Design of Pneumonia Panel

November 1, 2021

BEVERLY, Mass. USA – November 1, 2021 – LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary diagnostics, today announced it has finalized the design of the MiQLab™ Pneumonia Panel for companion animals and completed initial multiplex

Read More
  • Development Collaboration to Prevent Cancer Recurrence

    December 18, 2018

    First-Ever Human Health and Animal Health Drug Development Collaboration to Prevent Cancer Recurrence. Ethos Veterinary Health and Vuja De Sciences to utilize novel cellular assays of cancer metastasis and integration of pet dogs with cancer to empower innovative metastasis-focused drug development collaboration.

    Read More
  • ACI and Ethos Veterinary Health Form New Clinical Trial Network

    March 8, 2017

    Animal Clinical Investigation (ACI) and Ethos Veterinary Health (Ethos) have formed a strategic alliance offering a new mechanism to deliver market approval of pharmaceuticals and therapeutics in Animal Health. This relationship offers a unique opportunity for collaboration with organizations in the pharmaceutical industry, diagnostic developers and medical device companies.

    Read More
  • Ethos Diagnostic Science Conducts Accuracy Testing for Samsung

    February 7, 2017

    Samsung plans to extend the number of new testing analytes for In-Vitro Diagnostic (IVD) devices and also add veterinary products for imaging devices such as ultrasound system to establish a total solution for pet healthcare market which is likely to show a sustainable growth.

    Read More